In 2011, Retrasib reported a net profit of RON1.18 million.
Retrasib said its sales declined 3.1% to RON40 million in 2012, from RON41.3 million a year earlier.
Retrasib is 50.45%-owned by Cluj-based company Institut Proiect SA.
On Tuesday, Retrasib closed flat at RON0.2 a share in Bucharest. (EUR1=RON4.3885)